ClinicalTrials.Veeva

Menu

Surveillance Modified by Artificial Intelligence in Endoscopy (SMARTIE)

W

Wuerzburg University Hospital

Status

Completed

Conditions

Artificial Intelligence
Surveillance Endoscopy for Colorectal Cancer
Polyps of Colon
CADe

Treatments

Device: ENDOMIND

Study type

Interventional

Funder types

Other

Identifiers

NCT05006092
F-2021-047

Details and patient eligibility

About

Evaluation of an artificial intelligence system for polyp detection (CADe)

Full description

We aim to evaluate the artificial intelligence system ENDOMIND that supports endoscopist in detection of polyps during surveillance endoscopy for colorectal cancer. 1070 patients out of 6 gastroenterologic practice are randomized 1:1 for conventional surveillance colonoscopy vs. surveillance with AI support. Primary endpoint is Adenoma detection rate.

Enrollment

1,149 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • indication CRC surveillance endoscopy
  • indication post-polypectomy surveillance endoscopy
  • positive fecal immunochemical test in patients >=50 years

Exclusion criteria

  • reasonable suspicion of inflammatory bowl disease
  • reasonable suspicion of familiar polyposis Syndrome
  • Patient after radiation/resection of colonic parts

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,149 participants in 2 patient groups

surveillance endoscopy with CADe support
Experimental group
Description:
Endoscopy perfomed with CADe support.
Treatment:
Device: ENDOMIND
conventional surveillance endoscopy
No Intervention group
Description:
Endoscopy perfomed without CADe support.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems